Active Ingredient: Trientine
Trientine is indicated for the treatment of Wilson’s disease in adults, adolescents and children ≥5 years intolerant to D-penicillamine therapy.
For this indication, competent medicine agencies globally authorize below treatments:
Oral
225 - 600 mg
From 56.25 To 150 mg 4 time(s) per day every day
The starting dose in paediatrics is lower than for adults and depends on age and body weight.
The dose is usually between 225 mg and 600 mg per day in 2 to 4 divided doses.
The safety and efficacy of trientine in children aged <5 years have not been established. The pharmaceutical form is not suitable for administration to children <5 years.
It is important that trientine is given on an empty stomach, at least one hour before meals or two hours after meals and at least one hour apart from any other medicinal product, food, or milk.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.
